H.R. 1730 · 116th Congress · 2019–2020
Cancer Drug Parity Act of 2019
H.R. 1730 in the 116th Congress (2019–2020) was introduced on Mar 13, 2019, sponsored by Brian Higgins with 170 co-sponsors.
During the 116th Congress (2019–2020), Donald Trump was president, and Democrats held the House majority and Republicans the Senate majority.
- Status
- Introduced
- Introduced
- Mar 13, 2019
- Co-sponsors
- 170
- Policy area
- Health
What it does
Cancer Drug Parity Act of 2019 This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications.
Summary by the nonpartisan Congressional Research Service.
Sponsor
Brian Higgins (D-NY). Co-sponsors: 105 Democrats, 65 Republicans.
Where it stands
- IntroducedMar 13, 2019
- Passed the House—
- Passed the Senate—
- Sent to the President—
- Became law—
Latest action: Referred to the Subcommittee on Health. (Mar 14, 2019)
Other Health bills in the 116th Congress
- H.R. 259: Medicaid Extenders Act of 2019
- H.R. 1839: Medicaid Services Investment and Accountability Act of 2019
- S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
- S. 2047: A bill to provide for a 2-week extension of the Medicaid community mental health services…
- H.R. 3253: Sustaining Excellence in Medicaid Act of 2019
- H.R. 776: Emergency Medical Services for Children Program Reauthorization Act of 2019
- H.R. 1058: Autism Collaboration, Accountability, Research, Education, and Support Act of 2019
- H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
- H.R. 6201: Families First Coronavirus Response Act
- S. 1130: Scarlett's Sunshine on Sudden Unexpected Death Act
Committees
More
From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.
Cite or embed this page
Capitol Receipts, “H.R. 1730 (116th Congress): Cancer Drug Parity Act of 2019,” https://www.capitolreceipts.com/bill/116-hr-1730/cancer-drug-parity-act-of-2019 (accessed 2026-10-17).